C1 inhibitor‑mediated myocardial protection from chronic intermittent hypoxia‑induced injury

Fu,Jinrong; Guo,Furong; Chen,Cheng; Yu,Xiaoman; Hu,Ke; Li,Mingjiang

doi:10.3892/etm.2016.3592

C1 inhibitor‑mediated myocardial protection from chronic intermittent hypoxia‑induced injury

Authors:
- Jinrong Fu
- Furong Guo
- Cheng Chen
- Xiaoman Yu
- Ke Hu
- Mingjiang Li
View Affiliations

Affiliations: Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430000, P.R. China, Department of Urology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430000, P.R. China, Department of Respiratory Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430000, P.R. China
Published online on: August 12, 2016 https://doi.org/10.3892/etm.2016.3592
Pages: 2208-2214

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The optimal treatment for chronic intermittent hypoxia (CIH)-induced cardiovascular injuries has yet to be determined. The aim of the current study was to explore the potential protective effect and mechanism of a C1 inhibitor in CIH in the myocardium. The present study used a rat model of CIH in which complement regulatory protein, known as C1 inhibitor (C1INH), was administered to the rats in the intervention groups. Cardiomyocyte apoptosis was detected by terminal deoxynucleotidyl transferase‑mediated dUTP nick end labeling. The expression of proteins associated with the apoptotic pathway, such as B‑cell lymphoma 2 (Bcl‑2), Bax and caspase‑3 were detected by western blot analysis. The expression of complement C3 protein and RNA were also analyzed. C1INH was observed to improve the cardiac function in rats with CIH. Myocardial myeloperoxidase activity, a marker of neutrophil infiltration, was significantly decreased in the C1INH intervention group compared with the CIH control group, and cardiomyocyte apoptosis was significantly attenuated (P<0.05). Western blotting and reverse transcription‑polymerase chain reaction analysis indicated that the protein expression levels of Bcl-2 were decreased and those of Bax were increased in the CIH group compared with the normal control group, but the protein expression levels of Bcl-2 were increased and those of Bax were decreased in the C1INH intervention group, as compared with the CIH group. Furthermore, the CIH‑induced expression and synthesis of complement C3 in the myocardium were also reduced in the C1INH intervention group. C1INH, in addition to inhibiting complement activation and inflammation, preserved cardiac function in CIH‑mediated myocardial cell injury through an anti‑apoptotic mechanism.

View Figures

View References

1	Baguet JP, Barone-Rochette G, Tamisier R, Levy P and Pépin JL: Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol. 9:679–688. 2012. View Article : Google Scholar : PubMed/NCBI
2	Beaudin AE, Pun M, Yang C, Nicholl DD, Steinback CD, Slater DM, Edwards KE Wynne, Hanly PJ, Ahmed SB and Poulin MJ: Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: Implications for sleep apnea. J Am Heart Assoc. 3:e0008752014. View Article : Google Scholar : PubMed/NCBI
3	Chen L, Zhang J, Gan TX, Chen-Izu Y, Hasday JD, Karmazyn M, Balke CW and Scharf SM: Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Appl Physiol (1985). 104:218–223. 2008. View Article : Google Scholar : PubMed/NCBI
4	Yeung HM, Hung MW, Lau CF and Fung ML: Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res. 58:12–25. 2015. View Article : Google Scholar : PubMed/NCBI
5	Fu J, Lin G, Wu Z, Ceng B, Wu Y, Liang G, Qin G, Li J, Chiu I and Liu D: Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. Biochem Biophys Res Commun. 349:504–12. 2006. View Article : Google Scholar : PubMed/NCBI
6	Fu J, Lin G, Zeng B, Wu Z, Wu Y, Chu H, Qin G, Liang G, Li J, Gan X, et al: Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity. Biochem Biophys Res Commun. 350:162–168. 2006. View Article : Google Scholar : PubMed/NCBI
7	Chen L, Zhang J, Hu X, Philipson KD and Scharf SM: The Na⁺/Ca²⁺ exchanger-1 mediates left ventricular dysfunction in mice with chronic intermittent hypoxia. J Appl Physiol (1985). 109:1675–1685. 2010. View Article : Google Scholar : PubMed/NCBI
8	Liu D, Zhang D, Scafidi J, Wu X, Cramer CC and Davis AE: 3rd: C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood. 105:2350–2355. 2005. View Article : Google Scholar : PubMed/NCBI
9	Buerke M..Schwertz H..Seitz W..Meyer J..Darius H.: Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia–reperfusion injury in rabbits. J Immunol. 167:5375–5380. 2001. View Article : Google Scholar : PubMed/NCBI
10	Konings J, Govers-Riemslag JW, Spronk HM, Waltenberger JL and ten Cate H: Activation of the contact system in patients with a first acute myocardial infarction. Thromb Res. 132:138–142. 2013. View Article : Google Scholar : PubMed/NCBI
11	Onat A, Can G, Rezvani R and Cianflone K: Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta. 412:1171–1179. 2011. View Article : Google Scholar : PubMed/NCBI
12	Uyar IS, Onal S, Akpinar MB, Gonen I, Sahin V, Uguz AC and Burma O: Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation. Cardiovasc J Afr. 24:322–326. 2013. View Article : Google Scholar : PubMed/NCBI
13	Lu F, Fernandes SM and Davis AE III: The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 22:75–80. 2013. View Article : Google Scholar : PubMed/NCBI
14	Shi H, Williams JA, Guo L, Stampoulis D, Cordeiro M Francesca and Moss SE: Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis. Apoptosis. 20:433–443. 2015. View Article : Google Scholar : PubMed/NCBI
15	Ding W and Zhang X, Huang H, Ding N, Zhang S, Hutchinson SZ and Zhang X: Adiponectin protects rat myocardium against chronic intermittent hypoxia-induced injury via inhibition of endoplasmic reticulum stress. PLoS One. 9:e945452014. View Article : Google Scholar : PubMed/NCBI
16	Wang M, Lu L, Liu Y, Gu G and Tao R: FTY720 attenuates hypoxia-reoxygenation-induced apoptosis in cardiomyocytes. Exp Mol Pathol. 97:218–224. 2014. View Article : Google Scholar : PubMed/NCBI
17	Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lämmle B and Wuillemin WA: C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction. Crit Care Med. 30:1722–1728. 2002. View Article : Google Scholar : PubMed/NCBI
18	Emlen W, Li W and Kirschfink M: Therapeutic complement inhibition: New developments. Semin Thromb Hemost. 36:660–668. 2010. View Article : Google Scholar : PubMed/NCBI
19	Bäck J, Lood C, Bengtsson AA, Ekdahl KN and Nilsson B: Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus. Arthritis Res Ther. 15:R2062013. View Article : Google Scholar : PubMed/NCBI
20	Marcheix B, Carrier M, Martel C, Cossette M, Pellerin M, Bouchard D and Perrault LP: Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg. 85:530–535. 2008. View Article : Google Scholar : PubMed/NCBI
21	Collard CD, Väkevä A, Büküsoglu C, Zünd G, Sperati CJ, Colgan SP and Stahl GL: Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation. 96:326–333. 1997. View Article : Google Scholar : PubMed/NCBI
22	Devlin LA, Nguyen MD, Figueroa E, Gordon LE, Feldhoff PW and Lassiter HA: Effects of endotoxin administration and cerebral hypoxia-ischemia on complement activity and local transcriptional regulation in neonatal rats. Neurosci Lett. 390:109–113. 2005. View Article : Google Scholar : PubMed/NCBI
23	Bengtson A, Millocco I, Heideman M and Berggren H: Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass. J Cardiothorac Anesth. 3:305–310. 1989. View Article : Google Scholar : PubMed/NCBI
24	Gluszek J: Ischaemic heart disease and hypertension in patients with chronic obstructive pulmonary disease and obstructive sleep apnoea. Pneumonol Alergol Pol. 81:567–574. 2013.(In Polish). PubMed/NCBI